APA (7th ed.) Citation

ES, T., RR, A., EK, B., S, C., A, R., S, C., . . . PN, M. (2024). Updated Survival Follow-Up for Phase Ib Trial of the Histone Deacetylase Inhibitor Abexinostat With Pazopanib in Patients With Solid Tumor Malignancies. JCO precision oncology, 8, e2400328. https://doi.org/10.1200/PO.24.00328

Chicago Style (17th ed.) Citation

ES, Tsang, et al. "Updated Survival Follow-Up for Phase Ib Trial of the Histone Deacetylase Inhibitor Abexinostat With Pazopanib in Patients With Solid Tumor Malignancies." JCO Precision Oncology 8 (2024): e2400328. https://doi.org/10.1200/PO.24.00328.

MLA (9th ed.) Citation

ES, Tsang, et al. "Updated Survival Follow-Up for Phase Ib Trial of the Histone Deacetylase Inhibitor Abexinostat With Pazopanib in Patients With Solid Tumor Malignancies." JCO Precision Oncology, vol. 8, 2024, p. e2400328, https://doi.org/10.1200/PO.24.00328.